Asfar S. Azmi

20.2k total citations · 3 hit papers
217 papers, 10.5k citations indexed

About

Asfar S. Azmi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Asfar S. Azmi has authored 217 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Molecular Biology, 86 papers in Oncology and 52 papers in Cancer Research. Recurrent topics in Asfar S. Azmi's work include Cancer-related Molecular Pathways (32 papers), Nuclear Structure and Function (27 papers) and Pancreatic and Hepatic Oncology Research (25 papers). Asfar S. Azmi is often cited by papers focused on Cancer-related Molecular Pathways (32 papers), Nuclear Structure and Function (27 papers) and Pancreatic and Hepatic Oncology Research (25 papers). Asfar S. Azmi collaborates with scholars based in United States, Belgium and India. Asfar S. Azmi's co-authors include Fazlul H. Sarkar, Bin Bao, Aamir Ahmad, Ramzi M. Mohammad, Sanjeev Banerjee, Yiwei Li, Dejuan Kong, Shadan Ali, Zhiwei Wang and Philip A. Philip and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Asfar S. Azmi

215 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review

2013 937 citations Asfar S. Azmi, Bin Bao et al. profile →
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway

2009 527 citations Zhiwei Wang, Yiwei Li et al. Cancer Research profile →
Gastric cancer: a comprehensive review of current and future treatment strategies

2020 481 citations Rachel Sexton, Mohammed Najeeb Al Hallak et al. profile →

Peers

Countries citing papers authored by Asfar S. Azmi

Since Specialization

Citations

This map shows the geographic impact of Asfar S. Azmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asfar S. Azmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asfar S. Azmi more than expected).

Fields of papers citing papers by Asfar S. Azmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asfar S. Azmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asfar S. Azmi. The network helps show where Asfar S. Azmi may publish in the future.

Co-authorship network of co-authors of Asfar S. Azmi

This figure shows the co-authorship network connecting the top 25 collaborators of Asfar S. Azmi. A scholar is included among the top collaborators of Asfar S. Azmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asfar S. Azmi. Asfar S. Azmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges 2025 ·Signal Transduction and Targeted Therapy ·Khalil Choucair, (unknown), Md. Hafiz Uddin, Misako Nagasaka, Mohammed Najeeb Al Hallak, Philip A. Philip, (unknown), Boris Pasche, Asfar S. Azmi	2
2	RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth 2024 ·Cancer Letters ·(unknown), Amro Aboukameel, Husain Yar Khan, Md. Hafiz Uddin, Hyejeong Jang, Eliza W. Beal, (unknown), Yang Shi, Seongho Kim, Kay‐Uwe Wagner, (unknown), Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Muhammad Wasif Saif, Mohammed Najeeb Al Hallak, Boris Pasche, Asfar S. Azmi	2
3	Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers 2023 ·Molecular Cancer Therapeutics ·Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, (unknown), Md. Hafiz Uddin, (unknown), (unknown), Ibrahim Azar, Eliza W. Beal, (unknown), Steve Kim, (unknown), Erkan Baloglu, William Senapedis, Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Anthony F. Shields, Mohammed Najeeb Al Hallak, Asfar S. Azmi	5
4	Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers 2022 ·Cancer Research Communications ·Husain Yar Khan, Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton, (unknown), (unknown), Mohammed Najeeb Al Hallak, Steve Kim, (unknown), Yosef Landesman, Hirva Mamdani, Dipesh Uprety, Philip A. Philip, Ramzi M. Mohammad, Anthony F. Shields, Asfar S. Azmi	21
5	Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination 2022 ·Current Oncology ·Amr Mohamed, Asfar S. Azmi, L. Sylvia, Sree Harsha Tirumani, Amit Mahipal, (unknown), David L. Bajor, J. Eva Selfridge, Ahmed O. Kaseb	2
6	PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus 2021 ·Molecular Cancer Therapeutics ·(unknown), Md. Hafiz Uddin, Mohammed Najeeb Al Hallak, Amro Aboukameel, Yiwei Li, Steve Kim, (unknown), Gregory Dyson, Erkan Baloglu, William Senapedis, Yosef Landesman, Kay‐Uwe Wagner, Nerissa T. Viola, Bassel F. El‐Rayes, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	16
7	Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer 2021 ·Molecular Cancer ·Misako Nagasaka, Md. Hafiz Uddin, Mohammed Najeeb Al Hallak, Sarah Rahman, Suresh Kumar Balasubramanian, Ammar Sukari, Asfar S. Azmi	85
8	Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth 2020 ·Cancers ·Husain Yar Khan, (unknown), Rachel Sexton, Srikant Viswanadha, (unknown), Amro Aboukameel, Maria Diab, Mandana Kamgar, Mohammed Najeeb Al Hallak, (unknown), Anteneh Tesfaye, Steve Kim, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	28
9	KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? 2020 ·Cancer Treatment Reviews ·Misako Nagasaka, Yiwei Li, Ammar Sukari, Sai‐Hong Ignatius Ou, Mohammed Najeeb Al Hallak, Asfar S. Azmi	147
10	Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A review 2019 ·Critical Reviews in Oncology/Hematology ·Misako Nagasaka, Rachel Sexton, (unknown), Sarah Rahman, Asfar S. Azmi, Ammar Sukari	36
11	Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma 2019 ·Clinical Cancer Research ·Asfar S. Azmi, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Jasper E. Neggers, Dirk Daelemans, Amit Mahipal, Gregory Dyson, Mandana Kamgar, Mohammed Najeeb Al Hallak, Anteneh Tesfaye, Steve Kim, Vinod B. Shidham, Ramzi M. Mohammad, Philip A. Philip	40
12	Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance 2019 ·International Journal of Molecular Sciences ·Husain Yar Khan, (unknown), Misako Nagasaka, Amro Aboukameel, (unknown), Irfana Muqbil, (unknown), (unknown), Erkan Baloglu, Yosef Landesman, Ramzi M. Mohammad, Asfar S. Azmi, Ammar Sukari	30
13	PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors 2019 ·Cancers ·(unknown), Amro Aboukameel, Irfana Muqbil, Steve Kim, (unknown), Philip A. Philip, Ramzi M. Mohammad, Mandana Kamgar, Vinod B. Shidham, William Senapedis, Erkan Baloglu, Jing Li, Gregory Dyson, Yue Xue, Bassel F. El‐Rayes, Asfar S. Azmi	24
14	Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma 2016 ·Molecular Cancer Therapeutics ·Amro Aboukameel, Irfana Muqbil, William Senapedis, Erkan Baloglu, Yosef Landesman, Sharon Shacham, Michael Kauffman, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi	74
15	A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo 2013 ·Molecular Cancer Therapeutics ·Fardokht A. Abulwerdi, Chenzhong Liao, Meilan Liu, Asfar S. Azmi, Amro Aboukameel, Ahmed S.A. Mady, Thippeswamy Gulappa, Tomasz Cierpicki, Scott R. Owens, Tao Zhang, Duxin Sun, Jeanne A. Stuckey, Ramzi M. Mohammad, Zaneta Nikolovska‐Coleska	158
16	Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells 2011 ·Cancer Prevention Research ·Bin Bao, Zhiwei Wang, Shadan Ali, Aamir Ahmad, Asfar S. Azmi, Sanila H. Sarkar, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, (unknown), Fazlul H. Sarkar	286
17	Genistein Suppresses Doxorubicin Associated Genotoxicity in Human Lymphocytes 2011 ·Latin American Journal of Pharmacy ·Tanveer Beg, Yasir Hasan Siddique, Gulshan Ara, Asfar S. Azmi, Mohammad Afzal	1
18	Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations 2010 ·Molecular Cancer Therapeutics ·Asfar S. Azmi, Zhiwei Wang, Philip A. Philip, Ramzi M. Mohammad, Fazlul H. Sarkar	76
19	Pancreatic cancer: understanding and overcoming chemoresistance 2010 ·Nature Reviews Gastroenterology & Hepatology ·Zhiwei Wang, Yiwei Li, Aamir Ahmad, Sanjeev Banerjee, Asfar S. Azmi, Dejuan Kong, Fazlul H. Sarkar	284
20	TW-37, a Small-Molecule Inhibitor of Bcl-2, Inhibits Cell Growth and Induces Apoptosis in Pancreatic Cancer: Involvement of Notch-1 Signaling Pathway 2009 ·Cancer Research ·Zhiwei Wang, Asfar S. Azmi, Aamir Ahmad, Sanjeev Banerjee, Shaomeng Wang, Fazlul H. Sarkar, Ramzi M. Mohammad	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact